Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HLA epitopes and graft survival.

S Takemoto, P I Terasaki

    Clinical Transplants
    |January 1, 1991
    PubMed
    Summary

    Graft survival is negatively impacted by mismatches in numerous serologically defined residues, but not by non-serologically defined ones. Counting peptide epitopes significantly alters graft survival predictions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Landsteiner Award. HLA epitope matching.

    Transfusion·1992
    Same author

    HLA matching effect on five-year graft survival and half-life in the cyclosporine era.

    Kidney international. Supplement·1992
    Same author

    Prolongation of second heart transplants in rats.

    Transplantation·1992
    Same author

    Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry.

    The New England journal of medicine·1992
    Same author

    Effect of mismatching serologically defined residues on kidney transplant survival.

    Transplantation proceedings·1992
    Same author

    Beneficial effect of sharing six-antigen-matched cadaver kidneys in the United States.

    Transplantation proceedings·1992

    Area of Science:

    • Immunogenetics
    • Transplantation immunology
    • Histocompatibility

    Background:

    • Human Leukocyte Antigen (HLA) matching is critical for successful organ transplantation.
    • Conventional HLA matching relies on serological definitions, which may not fully capture immunogenic differences.
    • Epitope-based matching strategies are being explored to refine HLA compatibility assessment.

    Purpose of the Study:

    • To evaluate the impact of different HLA epitope definitions on predicting patient and graft survival.
    • To compare the predictive power of amino acid residues, heptapeptides, and conformational epitopes against conventional HLA matching.
    • To assess the effect of HLA antigen mismatches on graft outcomes using various epitope-based metrics.

    Main Methods:

    • Analysis of patient and graft survival data based on HLA specificities with up to 7 antigens mismatched.
    • Comparison of graft survival rates considering serologically defined residues, non-serologically defined residues, heptapeptides, and conformational epitopes.
    • Quantification of the impact of epitope counting on the difference in graft survival between low and high HLA mismatch groups.

    Main Results:

    • A high number of mismatched serologically defined residues was detrimental to graft survival.
    • Non-serologically defined residues did not significantly affect graft survival.
    • Counting serologically defined peptide epitopes doubled the observed difference in graft survival based on conventional A,B,DR mismatches.
    • Conformationally defined epitopes, derived from adjacent variable residues, showed poor correlation with graft outcome.

    Conclusions:

    • Serologically defined HLA epitopes are more informative than conventional antigen matching for predicting graft survival.
    • Non-serologically defined residues and conformational epitopes do not appear to be reliable predictors of transplant success in this context.
    • Epitope-based HLA matching strategies, particularly those focusing on serologically defined peptide epitopes, hold promise for improving transplant outcomes.

    Related Experiment Videos